We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$638M
AUM Growth
+$37.5M
Cap. Flow
-$628K
Cap. Flow %
-0.1%
Top 10 Hldgs %
26.89%
Holding
248
New
15
Increased
94
Reduced
104
Closed
9

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.44M
2
LDOS icon
Leidos
LDOS
+$3.34M
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$1.15M
4
META icon
Meta Platforms (Facebook)
META
+$453K
5
IWB icon
iShares Russell 1000 ETF
IWB
+$287K

Top Sells

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$2.99M
2
NWSA
NEWS CORPORATION CL-A
NWSA
+$1.1M
3
RS icon
Reliance Steel & Aluminium
RS
+$1.1M
4
QCOM icon
Qualcomm
QCOM
+$537K
5
IJT icon
iShares S&P Small-Cap 600 Growth ETF
IJT
+$326K

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.6%
2 Healthcare 13.6%
3 Consumer Staples 11.74%
4 Technology 10.54%
5 Financials 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IYW icon
201
iShares US Technology ETF
IYW
$25.3B
$308K 0.05%
15,620
-480
-3% -$9.32K
VTV icon
202
Vanguard Morningstar Value ETF
VTV
$192B
$306K 0.05%
4,387
-400
-8% -$28.2K
XLI icon
203
State Street Industrial Select Sector SPDR ETF
XLI
$32.9B
$305K 0.05%
6,567
– –
BDX icon
204
Becton Dickinson
BDX
$51.6B
$295K 0.05%
3,020
-143
-5% -$14K
XLV icon
205
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$292K 0.05%
5,763
– –
IWB icon
206
iShares Russell 1000 ETF
IWB
$49.1B
$289K 0.05%
+3,074
New +$287K
AIG icon
207
American International
AIG
$40.2B
$276K 0.04%
+5,674
New +$270K
ACAD icon
208
Acadia Pharmaceuticals
ACAD
$5.02B
$275K 0.04%
10,000
– –
BHI
209
DELISTED
Baker Hughes
BHI
$272K 0.04%
5,540
+165
+3% +$7.96K
TMO icon
210
Thermo Fisher Scientific
TMO
$230B
$261K 0.04%
2,830
+160
+6% +$14.5K
IVE icon
211
iShares S&P 500 Value ETF
IVE
$50.2B
$258K 0.04%
+3,292
New +$260K
NSIT icon
212
Insight Enterprises
NSIT
$4.57B
$252K 0.04%
13,332
– –
TEL icon
213
TE Connectivity
TEL
$58.7B
$252K 0.04%
+4,862
New +$243K
TJX icon
214
TJX Companies
TJX
$149B
$251K 0.04%
+8,910
New +$237K
VOD icon
215
Vodafone
VOD
$37.1B
$241K 0.04%
+6,717
New +$212K
SCHW
216
Charles Schwab
SCHW
$191B
$238K 0.04%
11,273
-380
-3% -$8.26K
FISV
217
Fiserv Inc
FISV
$28.3B
$234K 0.04%
9,252
-1,660
-15% -$40.1K
PCP
218
DELISTED
PRECISION CASTPARTS CORP
PCP
$229K 0.04%
1,009
-36
-3% -$8.12K
NBL
219
DELISTED
Noble Energy, Inc.
NBL
$228K 0.04%
3,400
– –
CPB icon
220
Campbell Soup
CPB
$6.98B
$220K 0.03%
5,412
-475
-8% -$21.3K
WOR icon
221
Worthington Enterprises
WOR
$2.8B
$217K 0.03%
10,223
-4,177
-29% -$89.4K
HAL icon
222
Halliburton
HAL
$30.1B
$214K 0.03%
+4,445
New +$208K
IYC icon
223
iShares US Consumer Discretionary ETF
IYC
$1.2B
$212K 0.03%
+7,700
New +$207K
A icon
224
Agilent Technologies
A
$43.4B
$211K 0.03%
+5,743
New +$194K
MO icon
225
Altria Group
MO
$115B
$211K 0.03%
6,147
– –
6 7 8
9
10

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q3 2013 Portfolio in Review

As of Q3 2013, Dowling & Yahnke held 248 positions worth $638M, up 6.2% from $601M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dowling & Yahnke's Q3 2013 filing shows 15 new, 94 increased, 104 reduced and 9 closed positions. Its largest new stake was Pfizer: 199,922 shares worth $5.45M. The largest sale was Ionis Pharmaceuticals, an estimated $2.99M.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dowling & Yahnke's largest Q3 2013 buy was Pfizer: 199,922 shares worth $5.45M.
  • Dowling & Yahnke added most to Leidos in Q3 2013, an estimated $3.34M increase.
  • Dowling & Yahnke's biggest Q3 2013 reduction was Ionis Pharmaceuticals, cutting an estimated $2.99M.
  • Dowling & Yahnke fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $1.1M.
  • Dowling & Yahnke's ten largest holdings make up 27% of its $638M portfolio in Q3 2013.
  • Dowling & Yahnke opened 15 new positions and closed 9 in Q3 2013.
  • Dowling & Yahnke's portfolio value rose 6.2% quarter-over-quarter to $638M.

Based on Dowling & Yahnke's 13F filing for Q3 2013, filed 12 Nov 2013.